… A systematic review and meta-analysis was carried out to compare the reactogenicity of
COVID-19 vaccines developed using different technologies: viral vector, mRNA, inactivated and …

… A few studies comparing the immunogenicity of heterologous and … COVID-19 vaccine, or
a second dose of the BNT162b2 COVID-19 vaccine after a first dose of mRNA-1273 COVID-19 …

… , and other factors make direct comparisons between vaccines difficult. We systematically …
universal vaccination and the goal of this analysis was a comparison between the vaccines. …

… Self-reported bias may also exist in the reactogenicity data, … in that moderately increased
reactogenicity compared with adults … of knowledge about the reactogenicity and adverse events …

… the reactogenicity and immunogenicity of the reduced and standard doses of the mRNA …
The most common solicited AEs after mRNA-based vaccine booster were injection site pain, …

… and reactogenicity data comparing all three homologous COVID-19 vaccine regimens
with heterologous combinations of ChAdOx-priming followed by either BNT- or mRNA-1273-…

… We did four primary comparisons and therefore we presented one-sided 98·75% CIs to
adjust for multiple testing for the primary outcome. Non-inferiority of a heterologous arm to its …

… The mRNA vaccines depend on boosting to achieve optimal … To achieve these deliverables
in the context of the COVID-19 … We have not attempted a cross-comparison between these …

… strategies among authorized COVID-19 vaccines, this … comparison with homologous
regimens, the reactogenicity profile was also rather moderate 13 . This contrasts with reactogenicity …

… mRNA vaccine (BTN162b2) had a remarkable better ability to produce NAbs and lower
reactogenicity … of COVID-19; therefore, we suggest that a booster could benefit these individuals. …